中文名称: | SR33805 | ||||
---|---|---|---|---|---|
英文名称: | SR33805 | ||||
别名: | SR33805 SR33805 | ||||
CAS No: | 121345-64-0 | 分子式: | C32H40N2O5 | 分子量: | 564.74 |
CAS No: | 121345-64-0 | ||||
分子式: | C32H40N2O5 | ||||
分子量: | 564.74 |
基本信息
产品编号: |
S10939 |
||||
产品名称: |
SR33805 |
||||
CAS: |
121345-64-0 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
564.74 |
-20℃ |
1个月 |
||
化学名: |
|||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
1.7707mL |
8.8536mL |
17.7073mL |
5mM |
0.3541mL |
1.7707mL |
3.5415mL |
10mM |
0.1771mL |
0.8854mL |
1.7707mL |
生物活性
产品描述 |
一种有效的Ca2+通道拮抗剂,在去极化和极化条件下的EC50值分别为4.1nM和33nM。SR33805阻止L型而不是T型Ca2+通道。SR33805可用于研究急性或慢性心脏衰竭。 |
|
靶点 |
type calcium channel 4.1nM (EC50,in depolarized conditions) |
L-type calcium channel 33nM (EC50,in polarized conditions) |
体外研究 |
SR33805 (0.01-10µM;3 d) inhibits growth factor-induced proliferation of SMC (0.2050<0.46µM) in a dose-dependent manner.SR33805 (10µM;10 min) restores the myocardial infarction (MI)-altered cell shortening without affecting the Ca2+ transient amplitude.SR33805 (10µM) decreases the activity of recombinant PKA. Cell Viability Assay |
|
Cell Line: |
Smooth muscle cells (SMC) |
|
Concentration: |
0.01,0.1,1,10µM |
|
Incubation Time: |
3 days |
|
Result: |
Inhibited in a dose-dependent manner FCS-,bFGF and PDGF-induced proliferation of porcine SMC with IC50s of 0.26±0.08,0.46±0.1 and 0.20±0.04µM,respectively. |
|
体内研究 |
SR33805 (20mg/kg;a single i.p.) improves end-systolic strain and fractional shortening of MI hearts in rats.SR33805 (5mg/kg/day;p.o.for 38 d) significantly reduces intimal hyperplasia in pigs. |
|
Animal Model: |
Male Wistar rats (5 weeks) are subjected to coronary artery ligature |
|
Dosage: |
0.2,2,20mg/kg |
|
Administration: |
A single i.p.injection |
|
Result: |
Increased significantly both end-systolic strain (ESS) and fractional shortening (FS) by about +38 and +26%,respectively at the dose of 20mg/kg.Did not affect other contractile parameters. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )